- Home
- OPRT vs ARCT Comparison
OPRT vs ARCT Comparison
Compare OPRT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRT
- ARCT
- Stock Information
- Founded
- OPRT 2005
- ARCT 2013
- Country
- OPRT United States
- ARCT United States
- Employees
- OPRT N/A
- ARCT N/A
- Industry
- OPRT Finance: Consumer Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- OPRT Finance
- ARCT Health Care
- Exchange
- OPRT Nasdaq
- ARCT Nasdaq
- Market Cap
- OPRT 298.8M
- ARCT 320.8M
- IPO Year
- OPRT 2019
- ARCT N/A
- Fundamental
- Price
- OPRT $6.00
- ARCT $18.51
- Analyst Decision
- OPRT Hold
- ARCT Strong Buy
- Analyst Count
- OPRT 2
- ARCT 9
- Target Price
- OPRT $8.00
- ARCT $49.57
- AVG Volume (30 Days)
- OPRT 507.5K
- ARCT 735.5K
- Earning Date
- OPRT 08-06-2025
- ARCT 08-11-2025
- Dividend Yield
- OPRT N/A
- ARCT N/A
- EPS Growth
- OPRT N/A
- ARCT N/A
- EPS
- OPRT N/A
- ARCT N/A
- Revenue
- OPRT $724,757,000.00
- ARCT $122,122,000.00
- Revenue This Year
- OPRT $28.27
- ARCT N/A
- Revenue Next Year
- OPRT $6.59
- ARCT $31.09
- P/E Ratio
- OPRT N/A
- ARCT N/A
- Revenue Growth
- OPRT N/A
- ARCT N/A
- 52 Week Low
- OPRT $2.37
- ARCT $8.04
- 52 Week High
- OPRT $9.25
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- OPRT 46.78
- ARCT 65.62
- Support Level
- OPRT $5.51
- ARCT $16.81
- Resistance Level
- OPRT $6.30
- ARCT $19.99
- Average True Range (ATR)
- OPRT 0.34
- ARCT 1.43
- MACD
- OPRT 0.00
- ARCT 0.39
- Stochastic Oscillator
- OPRT 36.11
- ARCT 83.03
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.